Lentiviral/retroviral vector large scale manufacturing

被引:0
|
作者
Bellintani, F. [1 ]
Neri, M. [1 ]
Rossetti, F. [1 ]
Cota, M. [1 ]
Crippa, L. [1 ]
Piovani, B. [1 ]
Simonetti, E. [1 ]
Allievi, L. [1 ]
Corbetta, S. [1 ]
Lorenzetti, F. [1 ]
Testasecca, A. [1 ]
Pedregal, A. [2 ]
Vallanti, G. [1 ]
机构
[1] MolMed SpA, Milan, Italy
[2] Pall Life Sci, New York, NY USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P457
引用
收藏
页码:A158 / A159
页数:2
相关论文
共 50 条
  • [31] Scaling up the Lentiviral Vector Manufacturing Using iCELLis500 Clinical Scale Fixed-Bed Bioreactor
    Lipponen, Eevi M.
    Leinonen, Hanna M.
    Oruetxebarria, Igor
    Valkama, Anniina J.
    Malinen, Joonas
    Turkki, Vesa
    Laaksonen, Iina
    Pietikainen, Sanna
    Kayhty, Piia
    Heikura, Tommi
    Yla-Herttuala, Seppo
    Lesch, Hanna P.
    MOLECULAR THERAPY, 2017, 25 (05) : 224 - 224
  • [32] Abolishing Retro-Transduction of Producer Cells in Lentiviral Vector Manufacturing
    Banos-Mateos, Soledad
    Lopez-Robles, Carlos
    Yubero, Maria Eugenia
    Jurado, Aroa
    Arbelaiz-Sarasola, Ane
    Lamsfus-Calle, Andres
    Arrasate, Ane
    Albo, Carmen
    Ramirez, Juan Carlos
    Fertin, Marie J.
    VIRUSES-BASEL, 2024, 16 (08):
  • [33] Industrial Lentiviral vector manufacturing using advanced process analytical technologies
    Williams, T.
    Sanches, R.
    Davies, L.
    Knevelman, C.
    Mitrophanous, K.
    Miskin, J.
    Blanchard-Emmerson, G.
    Watts, S.
    Evie, I.
    Churchwell, J.
    Dewhirst, O.
    Baradez, M.
    Marshall, D.
    Jones, P.
    HUMAN GENE THERAPY, 2019, 30 (11) : A36 - A37
  • [34] Consistency of Research Grade Lentiviral Vector Manufacturing Over 60 Batches
    Gorman, Wesley C.
    Buch, Pranali
    Maheno, Hannah
    Kuczewski, Michael
    Sutherland, Nolan
    Trimble, Logan
    Mancini, J. Dominic
    Angelino, Mark D.
    Segura, Maria Mercedes
    Kutner, Robert H.
    MOLECULAR THERAPY, 2015, 23 : S185 - S185
  • [35] Industrial Lentiviral Vector Manufacturing Using Advanced Process Analytical Technologies
    Davies, Lee
    Williams, Thomas
    Sanches, Rui
    Knevelman, Carol
    Clarkson, Nicholas
    McCloskey, Laura
    Law, Robert
    Mitrophanous, Kyriacos
    Miskin, James
    Blanchard-Emmerson, Greg
    Watts, Sam
    Evie, Isobelle
    Churchwell, John
    Dewhirst, Oliver
    Baradez, Marc-Olivier
    Marshall, Damian
    Rutley, James
    Arpino, James
    Shaw, Allen
    Gershater, Markus
    Jones, Peter
    MOLECULAR THERAPY, 2020, 28 (04) : 386 - 386
  • [36] A same lentiviral vector manufacturing process for both research and clinical application
    De Carluccio, G.
    Doria, M.
    Auricchio, A.
    di Bernardo, D.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A117 - A117
  • [37] GMP Manufacturing of Lentiviral Vectors: Scale-Up Considerations
    Davies, Lee
    Knevelman, Carol
    Carter, Rhian
    Pardo, Hanna
    Jones, Peter
    Mitrophanous, Kyriacos
    Miskin, James
    MOLECULAR THERAPY, 2019, 27 (04) : 412 - 412
  • [38] A Novel Retroviral Envelope as a Candidate for Pseudotyping Retroviral and Lentiviral Vectors
    Xu, Wenqin
    Russ, Jill
    Gorman, Kristen
    Delaney, Kyle
    Eiden, Maribeth V.
    MOLECULAR THERAPY, 2013, 21 : S202 - S203
  • [39] Gene delivery to the spinal cord: Comparison between lentiviral, adenoviral, and retroviral vector delivery systems
    Abdellatif, Ahmed A.
    Pelt, Jennifer L.
    Benton, Richard L.
    Howard, Russell M.
    Tsoulfas, Pantelis
    Ping, Peipei
    Xu, Xiao-Ming
    Whittemore, Scott R.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (03) : 553 - 567
  • [40] Lentiviral vector-mediated gene transfer to endotherial cells compared with adenoviral and retroviral vectors
    Sakoda, Tsuyoshi
    Kasahara, Nori
    Kedes, Larry
    Ohyanagi, Mitsumasa
    PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 2007, 37 (01): : 1 - 11